Evaluation of asthma prescription measures and health system performance based on emergency department utilization

Medical Care

Volumn 42, Issue 5, 2004, Pages 465-471

  Fuhlbrigge, Anne ^a,e   Carey, Vincent J ^a   Adams, Robert J ^a   Finkelstein, Jonathan A ^b   Lozano, Paula ^c   Weiss, Scott T ^a   Weiss, Kevin B ^d  

^a CHANNING LABORATORY   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d NORTHWESTERN UNIVERSITY   (United States)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Adherence; Asthma; Asthma drug therapy outcome assessment; Guidelines; Health services utilization; Managed care

Indexed keywords

ANTIASTHMATIC AGENT; ANTIINFLAMMATORY AGENT;

ADOLESCENT; ARTICLE; ASTHMA; CHI SQUARE DISTRIBUTION; CHILD; CROSS-SECTIONAL STUDY; EMERGENCY HEALTH SERVICE; FEMALE; HEALTH INSURANCE; HEALTH SERVICES RESEARCH; HUMAN; MALE; PRESCHOOL CHILD; STANDARD; STATISTICAL MODEL; STATISTICS; UNITED STATES; UTILIZATION REVIEW;

ADOLESCENT; ANTI-ASTHMATIC AGENTS; ANTI-INFLAMMATORY AGENTS; ASTHMA; CHI-SQUARE DISTRIBUTION; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; EMERGENCY SERVICE, HOSPITAL; FEMALE; HEALTH SERVICES RESEARCH; HUMANS; LOGISTIC MODELS; MALE; MANAGED CARE PROGRAMS; UNITED STATES; UTILIZATION REVIEW;

EID: 2542466051     PISSN: 00257079     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mlr.0000124249.84045.d7     Document Type: Article

References (23)

1. MacKinnon N, Flagstad M, Peterson C, et al. Disease management program for asthma: baseline assessment of resource use. Am J Health Syst Pharm. 1996;53:535-541.
2. National Asthma Education and Prevention Program. Expert Panel Report 2: Guidelines for the Diagnosis and Management of Asthma. Bethesda, MD: National Institutes of Health; 1997; Pub. No. 97-4051A.
3. Boushey H. Effects of inhaled corticosteroids on the consequences of asthma. J Allergy Clin Immunol. 1998;102:S5-S16.
4. Adams R, Fuhlbrigge A, Finkelstein J, et al. Impact of inhaled controller therapy on hospitalization and emergency room visits for children with asthma. Pediatrics. 2000;107:706-711.
5. Ducharme FM, Hicks GC. Anti-leukotriene agents compared to inhaled corticosteroids in the management of recurrent and/or chronic asthma. Cochrane Database Syst Rev. 2000;3:CD002314.
6. Juniper EF, Svensson K, O'Byrne PM, et al. Asthma quality of life during 1 year of treatment with budesonide with or without formoterol. Eur Respir J. 1999;14:1038-1043.
7. Adams R, Fuhlbrigge A, Finkelstein J, et al. Use of inhaled antiinflammatory medication in children with asthma in managed care settings. Arch Pediatr Adolesc Med. 2001;155:501-507.
8. Donahue J, Fuhlbrigge A, Finkelstein J, et al. Asthma pharmacotherapy and utilization by children in three managed care organizations. J Allergy Clin Immunol. 2000;106:1108-1114.
9. Donahue J, Weiss T, Livingston J, et al. Inhaled steroids and the risk of hospitalization for asthma. JAMA. 1997;277:887-891.
10. Griffiths C, Naish J, Sturdy P, et al. Prescribing and hospital admissions for asthma in east London. BMJ. 1996;312:481-482.
11. Aveyard P. Assessing the performance of general practices caring for patients with asthma. Br J Gen Pract. 1997;47:423-426.
12. Shelley M, Croft P, Chapman S, et al. Is the ratio of inhaled corticosteroid to bronchodilator a good indicator of the quality of asthma prescribing? Cross sectional study linking prescribing data to data on admissions. BMJ. 1996;313:1124-1126.
13. Bateman D, Eccles M, Campbell M, et al. Setting standards of prescribing performance in primary care: use of a consensus group of general practitioners and application of standards to practices in the north of England. Br J Gen Pract. 1996;46:20-25.
14. Finkelstein JA, Lozano P, Streiff KA, et al. Clinical effectiveness research in managed-care systems: Lessons from the Pediatric Asthma Care PORT. Patient Outcomes Research Team. Health Serv Res. 2002; 37:775-789.
15. Glauber JH, Fuhlbrigge AL. Stratifying asthma populations by medication use: how you count counts. Ann Allergy Asthma Immunol. 2002;88:451-454.
16. Hirschhorn L, Trnka Y, Onderdonk A, et al. Epidemiology of community-acquired Clostridium difficile-associated diarrhea. J Infect Dis. 1994;169:127-133.
17. Eastwood AJ, Sheldon TA. Organization of asthma care: what difference does it make? A systematic review of the literature. Quality in Health Care. 1996;5:134-143.
18. Vollmer WM, O'Hollaren M, Ettinger KM, et al. Specialty differences in the management of asthma. A cross-sectional assessment of allergists' patients and generalists' patients in a large HMO. Arch Intern Med. 1997;157:1201-1208.
19. Adams RJ, Fuhlbrigge AL, Guilbert TW, et al. Inadequate use of anti-inflammatory asthma medication in the United States-results of a US population-based survey. Am J Respir Crit Care Med. 2001;163:A493.
20. Dales RE, Kerr PE, Schweitzer I, Ressor K, Gougeon L, Dickinson G. Asthma management preceding an emergency department visit. Arch Intern Med. 1992;152:2041-2044.
21. Yellowlees PM, Ruffin RE. Psychological defenses and coping styles in patients following a life threatening attack of asthma. Chest. 1989;95:1298-1303.
22. Gottlieb DJ, Beiser AS, O'Connor GT. Poverty, race, and medication use are correlates of asthma hospitalization rates. A small area analysis in Boston. Chest. 1995;108:28-35.
23. Hofer T, Hayward R, Greenfield S, et al. The unreliability of individual physician 'report cards' for assessing the costs and quality of care in a chronic disease. JAMA. 1999;281:2098-2105.